Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Indication/Tumor Type||Response Type||Relevant Treatment Approaches||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|DDR2 L239R DDR2 T654I||lung squamous cell carcinoma||predicted - resistant||Dasatinib||Preclinical - Cell culture||Actionable||In a preclinical study, DDR2 T654I was identified as an acquired mutation in lung squamous cell carcinoma cells harboring DDR2 L239R that became resistant to Sprycel (dasatinib) in culture (PMID: 24296828).||24296828|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|